 Douglas Taren
Concepts (365)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin A Deficiency | 6 | 2019 | 26 | 1.570 |
Why?
| | Nutritional Status | 10 | 2024 | 326 | 1.500 |
Why?
| | Diet | 11 | 2023 | 1198 | 1.440 |
Why?
| | Agricultural Irrigation | 2 | 2019 | 2 | 1.170 |
Why?
| | Anemia, Iron-Deficiency | 3 | 2019 | 57 | 1.140 |
Why?
| | Ecosystem | 2 | 2023 | 563 | 1.140 |
Why?
| | Solar Energy | 2 | 2019 | 34 | 1.130 |
Why?
| | Nutritional Sciences | 4 | 2021 | 41 | 1.000 |
Why?
| | Food Supply | 4 | 2023 | 72 | 0.920 |
Why?
| | Acanthosis Nigricans | 1 | 2023 | 6 | 0.860 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 81 | 0.790 |
Why?
| | Education, Public Health Professional | 2 | 2015 | 6 | 0.790 |
Why?
| | Resilience, Psychological | 1 | 2023 | 122 | 0.760 |
Why?
| | Anthropometry | 4 | 2018 | 204 | 0.730 |
Why?
| | Climate Change | 1 | 2022 | 163 | 0.660 |
Why?
| | Premature Birth | 1 | 2023 | 310 | 0.640 |
Why?
| | Vitamin A | 7 | 2019 | 55 | 0.620 |
Why?
| | Thinness | 1 | 2019 | 89 | 0.620 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 308 | 0.620 |
Why?
| | Iron | 2 | 2019 | 282 | 0.600 |
Why?
| | Rural Population | 6 | 2017 | 511 | 0.590 |
Why?
| | Lasers | 1 | 2018 | 132 | 0.560 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2428 | 0.510 |
Why?
| | Crops, Agricultural | 1 | 2016 | 28 | 0.510 |
Why?
| | Poverty | 2 | 2017 | 497 | 0.500 |
Why?
| | Problem-Based Learning | 1 | 2015 | 77 | 0.450 |
Why?
| | Public Health | 2 | 2018 | 478 | 0.440 |
Why?
| | Benin | 3 | 2019 | 5 | 0.430 |
Why?
| | Program Evaluation | 4 | 2016 | 872 | 0.410 |
Why?
| | Energy Intake | 4 | 2023 | 454 | 0.410 |
Why?
| | Feeding Behavior | 6 | 2024 | 618 | 0.350 |
Why?
| | Microbiota | 1 | 2017 | 719 | 0.330 |
Why?
| | Humans | 56 | 2024 | 128019 | 0.320 |
Why?
| | Child, Preschool | 14 | 2024 | 10378 | 0.320 |
Why?
| | Maternal-Child Health Centers | 1 | 2008 | 9 | 0.310 |
Why?
| | Healthcare Disparities | 1 | 2015 | 579 | 0.300 |
Why?
| | Female | 41 | 2024 | 68016 | 0.300 |
Why?
| | Nutritional Physiological Phenomena | 3 | 2021 | 52 | 0.280 |
Why?
| | Socioeconomic Factors | 6 | 2019 | 1211 | 0.280 |
Why?
| | Infant | 10 | 2024 | 8912 | 0.280 |
Why?
| | Night Blindness | 2 | 2004 | 6 | 0.280 |
Why?
| | Electric Countershock | 9 | 1980 | 105 | 0.280 |
Why?
| | Zambia | 2 | 2024 | 55 | 0.280 |
Why?
| | Universities | 1 | 2008 | 399 | 0.250 |
Why?
| | Gardening | 2 | 2019 | 10 | 0.250 |
Why?
| | Prenatal Care | 2 | 2023 | 274 | 0.250 |
Why?
| | Infant, Newborn | 6 | 2024 | 5688 | 0.250 |
Why?
| | Prevalence | 5 | 2024 | 2541 | 0.250 |
Why?
| | Cooperative Behavior | 1 | 2008 | 424 | 0.250 |
Why?
| | Breast Feeding | 2 | 2023 | 422 | 0.250 |
Why?
| | Surveys and Questionnaires | 8 | 2020 | 5353 | 0.240 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5034 | 0.230 |
Why?
| | Body Mass Index | 6 | 2023 | 2260 | 0.230 |
Why?
| | Residential Facilities | 1 | 2024 | 7 | 0.230 |
Why?
| | Body Image | 3 | 2008 | 84 | 0.230 |
Why?
| | Kenya | 3 | 2022 | 107 | 0.230 |
Why?
| | Education, Distance | 2 | 2019 | 42 | 0.230 |
Why?
| | Child | 9 | 2024 | 20636 | 0.210 |
Why?
| | Infectious Disease Transmission, Vertical | 2 | 2022 | 170 | 0.210 |
Why?
| | Malnutrition | 1 | 2024 | 79 | 0.210 |
Why?
| | Starch | 1 | 2023 | 22 | 0.210 |
Why?
| | Adolescent | 10 | 2023 | 20158 | 0.210 |
Why?
| | Pregnancy Complications | 2 | 2005 | 487 | 0.210 |
Why?
| | Adult | 21 | 2023 | 35176 | 0.210 |
Why?
| | Sugars | 1 | 2023 | 37 | 0.210 |
Why?
| | Agriculture | 1 | 2023 | 92 | 0.210 |
Why?
| | Eating | 4 | 2011 | 368 | 0.200 |
Why?
| | Food Services | 3 | 1991 | 19 | 0.200 |
Why?
| | Dietary Carbohydrates | 1 | 2023 | 150 | 0.200 |
Why?
| | Male | 26 | 2024 | 62757 | 0.190 |
Why?
| | Vegetables | 2 | 2022 | 147 | 0.190 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2023 | 137 | 0.190 |
Why?
| | Knowledge | 1 | 2022 | 51 | 0.190 |
Why?
| | Food Assistance | 1 | 2022 | 29 | 0.190 |
Why?
| | Young Adult | 5 | 2019 | 12281 | 0.190 |
Why?
| | Curriculum | 4 | 2020 | 909 | 0.190 |
Why?
| | Pregnancy | 8 | 2023 | 6355 | 0.180 |
Why?
| | Arizona | 4 | 2015 | 78 | 0.180 |
Why?
| | Self-Management | 1 | 2023 | 161 | 0.180 |
Why?
| | Social Desirability | 2 | 2006 | 15 | 0.180 |
Why?
| | Early Diagnosis | 1 | 2022 | 234 | 0.180 |
Why?
| | HIV | 1 | 2022 | 225 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 1991 | 135 | 0.170 |
Why?
| | Nutrition Disorders | 3 | 2011 | 23 | 0.170 |
Why?
| | Diet Records | 6 | 2006 | 80 | 0.170 |
Why?
| | Mothers | 3 | 2022 | 729 | 0.170 |
Why?
| | Cacao | 1 | 1999 | 7 | 0.170 |
Why?
| | Birth Weight | 1 | 2023 | 499 | 0.170 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2000 | 95 | 0.160 |
Why?
| | Psychopharmacology | 1 | 1999 | 9 | 0.160 |
Why?
| | Integrative Medicine | 1 | 2019 | 10 | 0.160 |
Why?
| | Contraceptive Agents | 1 | 2019 | 64 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 1999 | 81 | 0.150 |
Why?
| | Contraception Behavior | 1 | 2019 | 97 | 0.150 |
Why?
| | Nutrition Assessment | 2 | 2017 | 85 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2000 | 137 | 0.150 |
Why?
| | Education, Medical, Undergraduate | 1 | 2001 | 176 | 0.150 |
Why?
| | Micronutrients | 1 | 2019 | 88 | 0.150 |
Why?
| | Family Planning Services | 1 | 2019 | 87 | 0.150 |
Why?
| | Nutrition Surveys | 2 | 2017 | 261 | 0.150 |
Why?
| | Dietary Fats | 1 | 2000 | 301 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 363 | 0.150 |
Why?
| | Nigeria | 3 | 2022 | 15 | 0.140 |
Why?
| | HIV Infections | 2 | 2022 | 2703 | 0.140 |
Why?
| | Orosomucoid | 1 | 2017 | 6 | 0.140 |
Why?
| | Observer Variation | 1 | 2018 | 310 | 0.140 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2017 | 20 | 0.140 |
Why?
| | Feeding and Eating Disorders | 1 | 1999 | 143 | 0.140 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 616 | 0.140 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 296 | 0.140 |
Why?
| | Self Disclosure | 2 | 2008 | 62 | 0.130 |
Why?
| | Ferritins | 1 | 2017 | 58 | 0.130 |
Why?
| | Middle Aged | 11 | 2019 | 30812 | 0.130 |
Why?
| | Retinal Detachment | 2 | 1995 | 56 | 0.130 |
Why?
| | Attitude of Health Personnel | 2 | 2020 | 1088 | 0.130 |
Why?
| | Pilot Projects | 2 | 2019 | 1559 | 0.130 |
Why?
| | Smoking Cessation | 2 | 2016 | 407 | 0.130 |
Why?
| | Bupropion | 1 | 2016 | 40 | 0.130 |
Why?
| | Intestinal Diseases, Parasitic | 3 | 1992 | 11 | 0.120 |
Why?
| | Schools, Public Health | 1 | 2015 | 3 | 0.120 |
Why?
| | Pregnancy Complications, Hematologic | 2 | 2012 | 18 | 0.120 |
Why?
| | Poverty Areas | 1 | 2015 | 35 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2018 | 3009 | 0.120 |
Why?
| | Hospitals, Rural | 1 | 2015 | 35 | 0.120 |
Why?
| | Urban Health | 1 | 2015 | 79 | 0.120 |
Why?
| | Scleral Buckling | 2 | 1995 | 18 | 0.120 |
Why?
| | Education, Graduate | 1 | 2015 | 35 | 0.120 |
Why?
| | Health Status Disparities | 1 | 2017 | 254 | 0.120 |
Why?
| | Stress, Physiological | 1 | 2017 | 411 | 0.110 |
Why?
| | C-Reactive Protein | 1 | 2017 | 396 | 0.110 |
Why?
| | Social Justice | 1 | 2015 | 77 | 0.110 |
Why?
| | Logistic Models | 2 | 2017 | 1975 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2017 | 338 | 0.110 |
Why?
| | Ascariasis | 3 | 1988 | 3 | 0.110 |
Why?
| | Health Personnel | 1 | 2020 | 645 | 0.110 |
Why?
| | Anemia | 2 | 2012 | 160 | 0.110 |
Why?
| | Growth | 1 | 1993 | 58 | 0.110 |
Why?
| | Tobacco Use Disorder | 1 | 2016 | 237 | 0.110 |
Why?
| | Vision Tests | 2 | 2004 | 16 | 0.100 |
Why?
| | Sodium Glutamate | 1 | 2012 | 9 | 0.100 |
Why?
| | Neurotoxins | 1 | 2012 | 26 | 0.100 |
Why?
| | Primary Health Care | 2 | 2022 | 1639 | 0.100 |
Why?
| | Irritable Bowel Syndrome | 1 | 2012 | 28 | 0.100 |
Why?
| | Program Development | 1 | 2015 | 357 | 0.100 |
Why?
| | Indians, Central American | 1 | 1992 | 5 | 0.100 |
Why?
| | India | 2 | 2023 | 170 | 0.100 |
Why?
| | Nepal | 3 | 2012 | 22 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2019 | 888 | 0.100 |
Why?
| | Fibromyalgia | 1 | 2012 | 55 | 0.100 |
Why?
| | Depression | 2 | 2006 | 1290 | 0.100 |
Why?
| | Self Concept | 2 | 2008 | 241 | 0.100 |
Why?
| | Chronic Disease | 1 | 2017 | 1690 | 0.090 |
Why?
| | Risk Factors | 7 | 2017 | 9696 | 0.090 |
Why?
| | Electrodes | 4 | 1979 | 103 | 0.090 |
Why?
| | Obstetric Labor, Premature | 1 | 1991 | 35 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1272 | 0.090 |
Why?
| | Glutamic Acid | 1 | 2012 | 228 | 0.090 |
Why?
| | Carotenoids | 3 | 2001 | 38 | 0.090 |
Why?
| | Cooking | 1 | 2011 | 58 | 0.090 |
Why?
| | Obesity | 2 | 2017 | 2859 | 0.090 |
Why?
| | Health Promotion | 2 | 2011 | 716 | 0.090 |
Why?
| | Xerophthalmia | 2 | 2004 | 6 | 0.080 |
Why?
| | Drug Therapy | 1 | 1990 | 77 | 0.080 |
Why?
| | Exercise | 3 | 2008 | 1917 | 0.080 |
Why?
| | Northwestern United States | 1 | 2008 | 55 | 0.080 |
Why?
| | Southwestern United States | 1 | 2008 | 91 | 0.080 |
Why?
| | Education, Continuing | 1 | 2008 | 39 | 0.080 |
Why?
| | Electrodes, Implanted | 2 | 1978 | 104 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2023 | 860 | 0.070 |
Why?
| | Premedication | 1 | 1987 | 41 | 0.070 |
Why?
| | Pain | 1 | 2012 | 748 | 0.070 |
Why?
| | Energy Metabolism | 3 | 2001 | 831 | 0.070 |
Why?
| | Vitamin E | 1 | 1987 | 119 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 1991 | 733 | 0.070 |
Why?
| | Retinol-Binding Proteins | 1 | 2005 | 14 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1994 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2005 | 108 | 0.060 |
Why?
| | Animals | 13 | 2017 | 34487 | 0.060 |
Why?
| | Electric Conductivity | 3 | 1979 | 94 | 0.060 |
Why?
| | Cardiac Catheterization | 2 | 1978 | 516 | 0.060 |
Why?
| | Feces | 4 | 2012 | 435 | 0.060 |
Why?
| | Wound Healing | 1 | 1987 | 298 | 0.060 |
Why?
| | Cryosurgery | 2 | 1995 | 56 | 0.050 |
Why?
| | Vitamin D Deficiency | 1 | 2005 | 176 | 0.050 |
Why?
| | Panama | 4 | 1992 | 11 | 0.050 |
Why?
| | Urban Population | 2 | 2004 | 440 | 0.050 |
Why?
| | Dogs | 7 | 1980 | 368 | 0.050 |
Why?
| | Educational Status | 2 | 2008 | 470 | 0.050 |
Why?
| | Gels | 2 | 1979 | 82 | 0.050 |
Why?
| | Uganda | 1 | 2022 | 72 | 0.050 |
Why?
| | Food Preferences | 2 | 2000 | 112 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 1990 | 1010 | 0.050 |
Why?
| | South Africa | 1 | 2022 | 192 | 0.050 |
Why?
| | Deuterium | 1 | 2001 | 86 | 0.050 |
Why?
| | Plant Oils | 1 | 2001 | 29 | 0.050 |
Why?
| | Time Factors | 6 | 2012 | 6479 | 0.040 |
Why?
| | Aged | 4 | 2016 | 21892 | 0.040 |
Why?
| | Public Sector | 1 | 2000 | 17 | 0.040 |
Why?
| | Cardiography, Impedance | 1 | 1980 | 8 | 0.040 |
Why?
| | Plethysmography, Impedance | 1 | 1980 | 5 | 0.040 |
Why?
| | Occupational Health Services | 1 | 2000 | 31 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 1994 | 1492 | 0.040 |
Why?
| | Biogenic Amines | 1 | 1999 | 4 | 0.040 |
Why?
| | Self Medication | 1 | 1999 | 10 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2001 | 95 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2000 | 47 | 0.040 |
Why?
| | Xanthines | 1 | 1999 | 18 | 0.040 |
Why?
| | Ghana | 1 | 2019 | 34 | 0.040 |
Why?
| | Food Analysis | 1 | 1999 | 21 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 1852 | 0.040 |
Why?
| | Psychological Techniques | 1 | 1999 | 7 | 0.040 |
Why?
| | Lactation | 1 | 2001 | 170 | 0.040 |
Why?
| | Social Responsibility | 1 | 2019 | 47 | 0.040 |
Why?
| | Milk, Human | 1 | 2001 | 149 | 0.040 |
Why?
| | Respiration | 1 | 1980 | 190 | 0.040 |
Why?
| | Thorax | 1 | 1979 | 41 | 0.040 |
Why?
| | Schools, Medical | 1 | 2000 | 130 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 1999 | 121 | 0.040 |
Why?
| | Encephalitozoon | 1 | 1998 | 2 | 0.040 |
Why?
| | Encephalitozoonosis | 1 | 1998 | 2 | 0.040 |
Why?
| | Water | 1 | 2001 | 439 | 0.040 |
Why?
| | Bias | 1 | 1999 | 196 | 0.040 |
Why?
| | Cholesterol | 1 | 2000 | 406 | 0.040 |
Why?
| | Peer Group | 1 | 2000 | 224 | 0.040 |
Why?
| | Focus Groups | 1 | 2000 | 452 | 0.040 |
Why?
| | Nicotine | 1 | 2000 | 302 | 0.040 |
Why?
| | Ointments | 1 | 1977 | 24 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2020 | 270 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2672 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2004 | 3324 | 0.030 |
Why?
| | Weight Gain | 1 | 2000 | 503 | 0.030 |
Why?
| | Education, Medical | 1 | 2000 | 243 | 0.030 |
Why?
| | Cell Membrane | 1 | 2000 | 725 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2706 | 0.030 |
Why?
| | Odds Ratio | 2 | 2000 | 1018 | 0.030 |
Why?
| | Placebos | 1 | 2016 | 201 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1934 | 0.030 |
Why?
| | Visual Acuity | 2 | 1995 | 322 | 0.030 |
Why?
| | Hookworm Infections | 2 | 2012 | 3 | 0.030 |
Why?
| | Smoking Prevention | 1 | 2016 | 161 | 0.030 |
Why?
| | Diarrhea, Infantile | 1 | 1994 | 8 | 0.030 |
Why?
| | Cryptosporidium parvum | 1 | 1994 | 11 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 1997 | 242 | 0.030 |
Why?
| | Cryptosporidiosis | 1 | 1994 | 21 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2019 | 493 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 170 | 0.030 |
Why?
| | Laser Therapy | 1 | 1995 | 131 | 0.030 |
Why?
| | Diarrhea | 1 | 1994 | 178 | 0.030 |
Why?
| | China | 1 | 1993 | 190 | 0.030 |
Why?
| | Oregon | 1 | 2012 | 69 | 0.030 |
Why?
| | Body Height | 1 | 1993 | 192 | 0.030 |
Why?
| | Body Weights and Measures | 1 | 2012 | 34 | 0.020 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2012 | 9 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 1813 | 0.020 |
Why?
| | Cultural Characteristics | 1 | 1992 | 62 | 0.020 |
Why?
| | Ferrous Compounds | 1 | 1991 | 23 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1943 | 0.020 |
Why?
| | Micronesia | 1 | 2011 | 3 | 0.020 |
Why?
| | Florida | 1 | 1991 | 92 | 0.020 |
Why?
| | Overweight | 1 | 2016 | 522 | 0.020 |
Why?
| | Parity | 1 | 1991 | 120 | 0.020 |
Why?
| | Ventricular Fibrillation | 3 | 1980 | 57 | 0.020 |
Why?
| | Nutritional Requirements | 1 | 2011 | 77 | 0.020 |
Why?
| | Body Weight | 2 | 1993 | 930 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2012 | 507 | 0.020 |
Why?
| | Pain Measurement | 1 | 2012 | 478 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 491 | 0.020 |
Why?
| | Vitamins | 1 | 1991 | 174 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1266 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2012 | 381 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2011 | 208 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2012 | 10110 | 0.020 |
Why?
| | Drug Interactions | 1 | 1990 | 361 | 0.020 |
Why?
| | Public Assistance | 1 | 1988 | 21 | 0.020 |
Why?
| | Pediatric Obesity | 1 | 2016 | 570 | 0.020 |
Why?
| | Smoking | 1 | 2016 | 1459 | 0.020 |
Why?
| | Health Services Research | 1 | 1991 | 389 | 0.020 |
Why?
| | Residence Characteristics | 1 | 1991 | 324 | 0.020 |
Why?
| | Mass Screening | 2 | 1997 | 1145 | 0.020 |
Why?
| | Lactose | 1 | 1987 | 7 | 0.020 |
Why?
| | Gastrointestinal Transit | 1 | 1987 | 6 | 0.020 |
Why?
| | Digestion | 1 | 1987 | 9 | 0.020 |
Why?
| | Statistics as Topic | 2 | 2001 | 303 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 426 | 0.020 |
Why?
| | Hematocrit | 1 | 1987 | 93 | 0.020 |
Why?
| | Hydrogen | 1 | 1987 | 65 | 0.020 |
Why?
| | Breath Tests | 1 | 1987 | 89 | 0.020 |
Why?
| | Diet, Reducing | 1 | 2008 | 86 | 0.020 |
Why?
| | Hydroxyproline | 1 | 1987 | 22 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 747 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 362 | 0.020 |
Why?
| | Personality Assessment | 1 | 2006 | 81 | 0.020 |
Why?
| | Mexico | 2 | 1998 | 190 | 0.020 |
Why?
| | Developing Countries | 1 | 1988 | 285 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 2 | 1998 | 370 | 0.020 |
Why?
| | Hemoglobins | 1 | 1987 | 336 | 0.020 |
Why?
| | Calcium | 1 | 1991 | 1182 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2703 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1994 | 4853 | 0.010 |
Why?
| | Mental Recall | 1 | 2006 | 185 | 0.010 |
Why?
| | Collagen | 1 | 1987 | 429 | 0.010 |
Why?
| | Surgical Procedures, Operative | 1 | 1987 | 243 | 0.010 |
Why?
| | Blood Proteins | 1 | 2005 | 239 | 0.010 |
Why?
| | Social Support | 1 | 2008 | 588 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 978 | 0.010 |
Why?
| | Sex Factors | 2 | 2000 | 1942 | 0.010 |
Why?
| | Calorimetry | 1 | 2001 | 64 | 0.010 |
Why?
| | Basal Metabolism | 1 | 2001 | 57 | 0.010 |
Why?
| | Palm Oil | 1 | 2001 | 2 | 0.010 |
Why?
| | Honduras | 1 | 2001 | 9 | 0.010 |
Why?
| | beta Carotene | 1 | 2001 | 21 | 0.010 |
Why?
| | Lutein | 1 | 2001 | 14 | 0.010 |
Why?
| | Administration, Cutaneous | 1 | 2000 | 121 | 0.010 |
Why?
| | Energy Transfer | 1 | 1980 | 51 | 0.010 |
Why?
| | Skin Physiological Phenomena | 1 | 1979 | 24 | 0.010 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2000 | 122 | 0.010 |
Why?
| | Fruit | 1 | 2000 | 131 | 0.010 |
Why?
| | Life Style | 1 | 2001 | 459 | 0.010 |
Why?
| | Research Support as Topic | 1 | 2000 | 111 | 0.010 |
Why?
| | Electronics, Medical | 1 | 1978 | 7 | 0.010 |
Why?
| | Rats | 1 | 1987 | 5199 | 0.010 |
Why?
| | Retrospective Studies | 2 | 1995 | 14404 | 0.010 |
Why?
| | Surface Properties | 1 | 1979 | 393 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 2001 | 7029 | 0.010 |
Why?
| | Social Behavior | 1 | 2000 | 286 | 0.010 |
Why?
| | Water Supply | 1 | 1998 | 74 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1977 | 80 | 0.010 |
Why?
| | Body Composition | 1 | 2001 | 644 | 0.010 |
Why?
| | Antioxidants | 1 | 2001 | 542 | 0.010 |
Why?
| | Calcium, Dietary | 1 | 1997 | 56 | 0.010 |
Why?
| | Dietary Fiber | 1 | 1997 | 49 | 0.010 |
Why?
| | Eligibility Determination | 1 | 1997 | 63 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2001 | 531 | 0.010 |
Why?
| | Heart Arrest | 1 | 1980 | 307 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1980 | 335 | 0.010 |
Why?
| | Coronary Disease | 1 | 1978 | 384 | 0.010 |
Why?
| | Colonic Polyps | 1 | 1997 | 87 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1977 | 314 | 0.010 |
Why?
| | Risk | 1 | 1997 | 850 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 338 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 658 | 0.010 |
Why?
| | Reoperation | 1 | 1995 | 541 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1998 | 1354 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1997 | 955 | 0.010 |
Why?
| | Models, Biological | 1 | 1977 | 1689 | 0.010 |
Why?
| | New York City | 1 | 1988 | 80 | 0.000 |
Why?
| | New York | 1 | 1988 | 124 | 0.000 |
Why?
| | Entamoebiasis | 1 | 1988 | 1 | 0.000 |
Why?
| | Trichuriasis | 1 | 1988 | 4 | 0.000 |
Why?
| | Parasite Egg Count | 1 | 1987 | 4 | 0.000 |
Why?
| | Ascaris | 1 | 1987 | 2 | 0.000 |
Why?
| | Giardiasis | 1 | 1988 | 20 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2614 | 0.000 |
Why?
| | Cohort Studies | 1 | 1997 | 5378 | 0.000 |
Why?
| | Electrocardiography | 2 | 1980 | 607 | 0.000 |
Why?
| | Seasons | 1 | 1988 | 498 | 0.000 |
Why?
| | United States | 1 | 2000 | 13785 | 0.000 |
Why?
| | Heart Massage | 1 | 1980 | 7 | 0.000 |
Why?
| | Heart Block | 1 | 1980 | 40 | 0.000 |
Why?
| | Epinephrine | 1 | 1980 | 140 | 0.000 |
Why?
| | Necrosis | 1 | 1980 | 228 | 0.000 |
Why?
| | Resuscitation | 1 | 1980 | 234 | 0.000 |
Why?
| | Respiration, Artificial | 1 | 1980 | 600 | 0.000 |
Why?
| | Myocardium | 1 | 1980 | 967 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1980 | 3936 | 0.000 |
Why?
|
|
Taren's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|